Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | N-myristoyltransferase 1 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | transcription factor LCR-F1 | 0.0033 | 0.0347 | 0.0302 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0193 | 0.8618 | 0.878 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.004 | 0.0666 | 0.0679 |
Entamoeba histolytica | glycylpeptide N-tetradecanoyltransferase, putative | 0.0216 | 0.9809 | 1 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0216 | 0.9809 | 0.5 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.004 | 0.0666 | 0.0629 |
Brugia malayi | hypothetical protein | 0.0033 | 0.0347 | 0.0302 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0216 | 0.9809 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0033 | 0.0347 | 0.0302 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0134 | 0.5583 | 0.5668 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0033 | 0.0347 | 0.0354 |
Plasmodium vivax | glycylpeptide N-tetradecanoyltransferase, putative | 0.0216 | 0.9809 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.004 | 0.0666 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0193 | 0.8618 | 0.878 |
Loa Loa (eye worm) | N-myristoyltransferase 2 | 0.0216 | 0.9809 | 1 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0134 | 0.5583 | 0.5668 |
Trypanosoma brucei | N-myristoyl transferase, putative | 0.0216 | 0.9809 | 0.5 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0142 | 0.5971 | 0.5683 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0347 | 0.0302 |
Trichomonas vaginalis | set domain proteins, putative | 0.022 | 1 | 1 |
Schistosoma mansoni | N-myristoyltransferase | 0.0216 | 0.9809 | 1 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0028 | 0.0053 | 0.0054 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0131 | 0.5387 | 0.5492 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.004 | 0.0666 | 1 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0134 | 0.5583 | 0.5668 |
Loa Loa (eye worm) | acetyltransferase | 0.0134 | 0.5583 | 0.5668 |
Giardia lamblia | CDC72 | 0.0216 | 0.9809 | 1 |
Plasmodium falciparum | glycylpeptide N-tetradecanoyltransferase | 0.0216 | 0.9809 | 1 |
Echinococcus granulosus | glycylpeptide N tetradecanoyltransferase | 0.0216 | 0.9809 | 1 |
Echinococcus multilocularis | glycylpeptide N tetradecanoyltransferase | 0.0216 | 0.9809 | 1 |
Leishmania major | N-myristoyl transferase, putative | 0.0216 | 0.9809 | 0.5 |
Brugia malayi | N-myristoyltransferase 2 | 0.0216 | 0.9809 | 1 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0216 | 0.9809 | 0.9795 |
Trypanosoma brucei | N-myristoyltransferase | 0.0216 | 0.9809 | 0.5 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0036 | 0.0496 | 0.0157 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 10 uM | Inhibition of Candida albicans N-myristoyltransferase (NMT) with peptide GNAASARR-NH2 and [3H]-myristoyl-CoA at 1 uM | ChEMBL. | No reference |
IC50 (binding) | = 10 uM | Inhibition of Candida albicans N-myristoyltransferase (NMT) with peptide GNAASARR-NH2 and [3H]-myristoyl-CoA at 1 uM | ChEMBL. | No reference |
IC50 (binding) | = 52 uM | Tested for Inhibitory concentration against human N-myristoyltransferase (NMT) in radiochemical HPLC end point assay with peptide GNAASARR-NH2 and [3H]-myristoyl-CoA radioligand at 1 uM | ChEMBL. | No reference |
IC50 (binding) | = 52 uM | Tested for Inhibitory concentration against human N-myristoyltransferase (NMT) in radiochemical HPLC end point assay with peptide GNAASARR-NH2 and [3H]-myristoyl-CoA radioligand at 1 uM | ChEMBL. | No reference |
Ratio (binding) | = 5 | Selectivity ratio of the IC50 against human NMT to the IC50 against C. albicans NMT was determined | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.